OSH has recently received a confidential non-binding and indicative change of control proposal. That proposal has been carefully assessed by OSH's Board, and Senior Management (excluding Dr Wulff), and our advisers Goldman Sachs and Macquarie Capital, as well as legal advisers Allens. Following that assessment, the proposal was rejected as it was determined to not be in OSH shareholders' best interests on the terms and value proposed.
OSH Price at posting:
$3.67 Sentiment: None Disclosure: Held
